Effects of Motion and Tissue Weighting on PET Myocardial Blood Flow Estimates

Similar documents
Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: a technical perspective

Conflict of Interest Disclosure

Normal LV Ejection Fraction Limits Using 4D-MSPECT: Comparisons of Gated Perfusion and Gated Blood Pool SPECT Data with Planar Blood Pool

Myocardial Blood Flow from Dynamic PET using Independent Component Analysis

Comparison between 1-compartmental and 2-compartmental model in calculation of myocardium blood flow in 82 Rb PET imaging

Calculating Coronary Flow Reserve with CZT SPECT Fundamentals and Applications. White Paper

Typical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?

TW Hamilton, EP Ficaro, TA Mitchell, JN Kritzman, JR Corbett University of Michigan Health System, Ann Arbor, MI

PET is currently the accepted gold standard in noninvasive

Pearls & Pitfalls in nuclear cardiology

Myocardial Perfusion: Positron Emission Tomography

Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN

RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING

Preview of Presentation

SPECT or PET for Cardiovascular Screening in High-Risk Patients

海外研究留学報告 福島賢慈 東京女子医科大学 画像診断 核医学部 核医学地方会 2011 Jan

Animals. Male C57Bl/6 mice (n=27) were obtained from Charles River (Sulzfeld, Germany) and

Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine

Myocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas

Detection Of Functional Significance of Coronary Stenoses Using Dynamic. Values Of Myocardial Blood Flow And Coronary Flow Reserve

Qualitative and Quantitative Assessment of Perfusion

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

CT Myocardial Perfusion

MPI Overview. Artifacts and Pitfalls in MPI. Acquisition and Processing. Peeyush Bhargava MD, MBA

OPTIMIZATION OF Rb-82 PET ACQUISITION AND RECONSTRUCTION PROTOCOLS FOR MYOCARDIAL PERFUSION DEFECT DETECTION

Photon Attenuation Correction in Misregistered Cardiac PET/CT

CT Myocardial Perfusion: Is there Added Value to Coronary CT?

The Status and Future of PET Myocardial Blood Flow Quantification Software

NIH Public Access Author Manuscript Mol Imaging Biol. Author manuscript; available in PMC 2011 April 1.

Old and new insights into viability:perfusion and Perfusion Reserve

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

ASNC/SNMMI POSITION STATEMENT

Hybrid imaging of the heart

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin

Integrated PET/CT systems State of the art and Clinical Applications

Integrated Report Generation for Myocardial Perfusion SPECT: Efficiency Comparison to Report Dictation

Gender differences in CT calcium scoring: A phantom study

Myocardial viability testing. What we knew and what is new

CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82

RESEARCH ARTICLE. Image-Derived Input Function from Cardiac Gated Maximum a Posteriori Reconstructed PET Images in Mice

PET-MRI in Cardiac Imaging: Initial Experience

Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation.

State-of-the-Art SPECT/CT: Cardiac Imaging

CT Perfusion. U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging

CARDIAC MRI. Cardiovascular Disease. Cardiovascular Disease. Cardiovascular Disease. Overview

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Appearances can be deceiving.

European Journal of Hybrid Imaging. Opstal TSJ 1,3*, Knol RJJ 1,2, Cornel JH 2,3, Wondergem M 1,2 and van der Zant FM 1,2

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.

Dual Energy CT of the Heart: Perfusion and Beyond

Form 4: Coronary Evaluation

Alignment of Cardiac Structures in [15O]H2O Perfusion PET Studies

Cardiovascular Imaging

How to Evaluate Microvascular Function and Angina. Myeong-Ho Yoon Ajou University Hospital

Stress only Perfusion Imaging

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)

Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes

PET for the Evaluation of Myocardial Viability

Positron emission tomography and molecular imaging

IMR in acute STEMI and clinical outcomes

PET: quantification of perfusion and beyond

Form 4: Coronary Evaluation

Validation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner

3D-stress echocardiography Bernard Cosyns, MD, PhD

MOLINA HEALTHCARE OF MICHIGAN PRIOR AUTHORIZATION / PRE-SERVICE REVIEW GUIDE IMAGING CODES REQUIRING PRIOR AUTHORIZATION EFFECTIVE 1/1/2014

Case-Based Pitfalls of SPECT and PET: Recognizing and Working with Artifacts

Biases affecting tumor uptake measurements in FDG-PET

New Challenges in Nuclear Cardiology Practice

Hybrid Imaging Improving Nuclear Cardiology Practice

CT or PET/CT for coronary artery disease

Conflict of Interest Disclosure

Diffuse Disease and Serial Stenoses

Fundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC

Rubidium-82 myocardial perfusion PET/CT

Feasibility of a New C-arm angiography (DYNA-CT) based three-dimensional algorithm in combination with myocardial perfusion assessment

Control of Myocardial Blood Flow

Habib Zaidi Rene Nkoulou Sarah Bond Aylin Baskin Thomas Schindler Osman Ratib Jerome Declerck

Form 4: Coronary Evaluation

Debate Should we use FFR? I will say NO.

Diffuse Disease and Serial Stenoses. Bernard De Bruyne Cardiovascular Center Aalst Belgium

Fractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου

High Speed Myocardial Perfusion SPECT: Validation of Quantitative Analysis and use in Low Dose Stress only Protocol

Previous MI with no intervention

05/02/ CPT Preauthorization Groupings Effective May 2, Computerized Tomography (CT) Abdomen 6. CPT Description SEGR CT01

MINIMIZING RADIATION EXPOSURE

Imaging congestive heart failure: role of coronary computed tomography angiography (CCTA)

Advantages of PET Myocardial Imaging

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

Mechanisms and role of contrast echocardiography

Stable Angina: Indication for revascularization and best medical therapy

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Form 4: Coronary Evaluation

I have no financial disclosures

On the feasibility of speckle reduction in echocardiography using strain compounding

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)

Perfusion CMR: State of the Art

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

Modifi ed CT perfusion contrast injection protocols for improved CBF quantifi cation with lower temporal sampling

Transcription:

Effects of Motion and Tissue Weighting on PET Myocardial Blood Flow Estimates Benjamin C. Lee 1, Jonathan B. Moody 1, Venkatesh L. Murthy 2, James R. Corbett 2, Edward P. Ficaro 2 1 INVIA Medical Imaging Solutions, Ann Arbor, MI, 2 University of Michigan Health System, Ann Arbor, MI Disclosures: BC Lee, J Moody, Employee: INVIA; VL Murthy, Stock Shareholder: GE, Grant: INVIA; JR Corbett, EP Ficaro, Owners: INVIA.

Introduction Background Relative PET perfusion imaging provides suboptimal clinical information of diffuse or multistenosis coronary artery disease (CAD) Dynamic 82 Rb PET measurements of myocardial blood flow (MBF) and coronary flow reserve (CFR) may improve those prognostic and diagnostic yields Respiratory motion may have an effect on the estimates of MBF and CFR

Introduction Background (cont d) Dataset with motion with blood pool spillover into myocardium Severe Motion Uncorrected Manual Motion Corrected

Introduction Background (cont d) Time activity curves (TAC) affected by motion Severe Motion TAC Manual Motion Corrected TAC 4

Activity (kbq/ml) Introduction Background (cont d) Weighting tissue data may reduce motion effects LV Blood LAD Tissue Tissue Weight 200 150 100 50 0 0 60 120 180 240 300 360 Time (sec)

Introduction Objectives Identify prevalence of respiratory motion in dynamic PET myocardial perfusion images Study respiratory motion effects on MBF and CFR estimates Manual motion correction is labor intensive therefore investigate effect of preferentially increasing weight in tissue-phase frames to offset respiratory motion blood-phase frames

Methods Data Acquisition 53 sequential patients referred for dynamic stress/rest 82 Rb PET imaging Acquired in 3-D list mode on Siemens Biograph mct 40 30 serial dynamic frames over 6.7 minutes 16 x 5sec, 6 x 10sec, 3 x 20sec, 4 x 30sec, 1 x 80sec Reconstructed using 3D-OSEM with PSF Attenuation corrected, 3 iterations with 24 subsets, no post-filtering 7

Methods Motion Analysis Visually assessed motion by maximum shift btwn. Blood pool in first 2 min. (first 20 frames) LV surface generated from post 2 min. as reference Categorized respiratory motion as: Minimal motion (sub-pixel shift) Moderate motion (1/2 wall thickness shift) Severe motion (full wall thickness shift) Datasets with moderate or severe respiratory motion were manually corrected for comparison 8

Methods Kinetic Analysis ROI method sampled left ventricular (LV) blood pool and tissue time activity curves (TAC) Kinetic fitting using Corridor4DM software (INVIA) 1-tissue compartment with Lortie flow model Weighting models No weighting Weighting using frame duration, decay correction factor, and activity concentration Evaluated mean MBF, CFR, and relative changes 9

Results Prevalence of Motion Motion was observed in 85% of the datasets with majority 55% of those with bloodpool in region Motion by Severity Motion* by Region Severe Moderate Minimal LAD LCX 100% 75% 50% 25% 17% 13% 15% 40% 53% 46% 43% 34% 39% 85% 100% 75% 50% 25% 14% 18% 68% 22% 18% 36% 42% 27% 55% 0% Stress Rest All 0% Stress Rest All *moderate and severe only

Results Change Bias, LOA MBF and CFR Effects from Motion Compared to motioncorrected, mean MBF and CFR changed < 5%, except for stress MBF with severe motion of 6% Mean stress MBF with severe motion had mean bias of 0.1* and 95% limits of agreement (LOA)** of 0.7* 10% 5% 0% 1.0 0.0 Moderate Motion Severe Motion * p < 0.05 * * * Stress MBF Rest MBF CFR Stress MBF Rest MBF CFR *(ml/min/g), **95% LOA=1.96 Stdev -1.0

Results Regional Change Regional Bias, LOA Regional Stress MBF Effects from Motion Mean stress MBF changes were less than 6% except for with severe motion of 20% with severe motion had mean stress MBF bias of 0.5* and 95% limits of agreement of 1.6* *(ml/min/g) 25% 20% 15% 10% 5% 0% 3.0 2.0 1.0 0.0-1.0-2.0 Moderate Motion * p < 0.05 * LAD Stress MBF LAD Stress MBF Severe Motion * LCX Stress MBF LCX Stress MBF * Stress MBF Stress MBF

Results Regional Change Regional Bias, LOA Regional CFR Effects from Motion Mean CFR changes were less than 4% except for with severe motion of 18% with severe motion had mean CFR bias of 0.4 and 95% limits of agreement of 1.9 20% 15% 10% 5% 0% -5% 3.0 2.0 1.0 0.0-1.0-2.0 Moderate Motion Severe Motion * p < 0.05 LAD CFR LCX CFR CFR LAD CFR LCX CFR CFR * *

Results Stress MBF Change Stress MBF Bias, LOA Tissue Weighting Effects on Stress MBF Tissue weighting (nonmotion corrected) did not reduce mean stress MBF bias Especially for with severe motion, change was only -1.4% point 95% limits of agreement did not decrease significantly 25% 20% 15% 10% 5% 0% 3.0 2.0 1.0 0.0-1.0-2.0 * p < 0.05 No Weight Weight

Results CFR Change CFR Bias, LOA Tissue Weighting Effects on CFR Tissue weighting (nonmotion corrected) did not reduce mean CFR bias with severe motion increased with change of just 1.4% point 25% 20% 15% 10% 5% 0% 3.0 * p < 0.05 No Weight Weight 95% limits of agreement did not decrease significantly 2.0 1.0 0.0-1.0-2.0

Limitations Manual Motion Correction Possible miscategorization of severe, moderate, and minimal respiratory motion No Tissue Phase (>2min) Motion Correction Reference LV surfaces generated from tissue phase Longer frame durations are motion averaged Lower count statistics in later frames

Conclusions Respiratory motion is common (up to 85%) in the blood pool phase due to fast kinetics of the tracer and the short time sampling. Increases in MBF and CFR estimates were observed in studies with moderate and severe respiratory motion, and substantially in the. Tissue weighting did not have desired result in greatly reducing respiratory motion induced bias. Motion correction is necessary to reduce bias in MBF and CFR.

Appendix

Activity (kbq/ml) Appendix: Frame Duration Weighting Weighting tissue data with frame duration only may reduce respiratory motion effects further LV Blood LAD Tissue Tissue Weight Duration Weight 200 150 100 50 0 0 60 120 180 240 300 360 Time (sec)

Stress MBF Change Appendix: Frame Duration Weighting Tissue Weighting Effects on Stress MBF Compared to no weighting, stress MBF with frame duration only weighting changed -2% points, except for with severe motion of -0.8% point No Weight Weight Duration Weight 25% 20% * p < 0.05 * 15% 10% 5% * 0% -5% (Minimal) (Minimal)

Appendix: Frame Duration Weighting CFR Change Tissue Weighting Effects on CFR Compared to no weighting, CFR with frame duration only weighting changed 1% point, except for with moderate and severe motion of 3% and 5% points respect. 25% 20% 15% * p < 0.05 No Weight Weight Duration Weight * 10% 5% * * 0% -5% (Minimal) (Minimal)